Medium-term plans, capital spending, new plants, products and drug approvals from Japanese companies.
Asahi Diamond Industrial and Tokyo Seimitsu will each inject ¥615mn into their 50-50 joint venture to equip a planned Thai hub-blade plant, with operations targeted for April 2028 and a minor near-term earnings effect.
Liberaware has been selected for Tokyo's second-round SusHi Tech Global growth programme, which offers up to ¥200mn and up to 18 months of support, while the drone maker says the effect on its results is still under review.
Yamazaki Baking will revise prices on some bread, sweet buns and cakes from January 2027 shipments, citing flour, fats, fillings, labour and logistics costs, while food profit rose 8.1% and its convenience-store losses widened.
PowerX began shipping its 10-foot Mega Power 2500 battery system on 26 October; 444 of 477 firm orders are scheduled for 2027, and the company expects only a minor effect on this year's forecast.
Otsuka says its final two-year VISIONARY data show one composite kidney event among 259 VOYXACT patients against 28 among 251 on placebo, and a supplemental FDA filing seeking full approval is complete.
PowerX says production is on plan and its 99.2% progress figure counts built inventory, not shipments or revenue, while it describes the Hokkaido plant's move to July 2028 as a capital-efficiency decision rather than a production problem.
A Japanese drug panel concluded Steboronine can be approved for recurrent meningioma, but formal approval is pending, and Stella Pharma expects only a slight effect on earnings in the year to March 2027.
Fuji Seal International's board resolved to begin union consultations toward closing Fuji Seal France, with the final decision to follow talks under local law and the consolidated earnings impact still under review.
Koito Manufacturing has resolved to dissolve and liquidate its wholly owned Hubei car-lighting maker, citing the EV shift, local Chinese rivals and weaker sales at its Japanese carmaker customers, while calling the earnings hit minor.
BuySell Technologies says AI already handles about 70% of its contract calls and about 40% of follow-up calls, and it expects roughly ¥600mn in labor-cost restraint next year across its call-centre and marketing departments.
Nakamoto Packs started its Saitama process-development coater at the end of September, targeting battery materials, while first-half operating profit rose 52.4% to ¥2.45bn and secondary-battery sales were still spot orders only.
Kringle Pharma said the FDA review of its IND for oremepermin alfa has ended and the application is in effect; the company is preparing a US Phase III trial in acute spinal cord injury, with no partner or start date named.
GMO Internet's board approved a planned ¥26.1bn purchase of up to 116 Nvidia B300 servers and a data center in Ishikari, Hokkaido, with acquisitions scheduled from August 2027.
Aviation Capital Group, the US lessor Tokyo Century is selling half of to Itochu, has signed for 75 A320neo-family jets with a catalog value of about ¥1.856tn, delivering from 2032 to 2035; the actual price is undisclosed.
Pharma Foods says a hospital and care-home food supplier joined the group on October 6, while its new three-year plan aims for ¥72bn in sales by July 2029 from ¥63.2bn now.
Astroscale's October briefing details a £15mn UK Ministry of Defence order and a €13.2mn French deorbit mission contracted through Exotrail, together ¥5.4bn of orders since August, while first-quarter operating loss was ¥2.75bn.
GO, Waymo and Nihon Kotsu aim for driverless Tokyo taxis in 2027, scaling to about 100 vehicles only after permits are obtained, while GO's app business lifted quarterly operating profit to ¥3.04bn.
BayCurrent targets ¥500bn in revenue and a 40% EBITDA margin in its 2030 plan, and now holds back only about 25% of forecast revenue in cash, with the surplus going to investment and buybacks.
VRAIN Solution's AI inspection system has been adopted for a project at a large semiconductor-ceramics maker's domestic site, in a half-year of ¥1.88bn in sales, up 80.0%, and ¥1.31bn of backlog.
Star seeds Digital will buy 32 GPU servers and lease them for 24 months in a deal worth about $18.33mn, with payment due before delivery and revenue planned at acceptance, which could slip into the year ending February 2028.
Osaka Organic Chemical now plans to spend about ¥20bn on its Yamagata semiconductor-materials plant, twice the December figure, with construction pushed to 2027 and completion to 2029 after higher costs and a revised equipment list.
Members' president says overconfidence, not only the market, led to a 92% cut in full-year operating profit guidance, while the group aims to produce 230 AI specialists this year and has no layoffs planned at present.
Marumae says semiconductor orders now exceed its production capacity and has raised its capital spending plan to ¥5.6bn for the year to August 2027, while warning that customer demands are not fully in its ¥28bn sales guide.
Kose Holdings received 199 applications for its early retirement program against a target of about 80, and expects a ¥2.5bn special loss in the third quarter that an office property sale gain should offset, leaving guidance unchanged.